
IHC-P analysis of human lung carcinoma tissue using GTX86945 Caspase 9 (cleaved Asp315) antibody. The picture on the right is blocked with the synthesized peptide.
Caspase 9 (cleaved Asp315) antibody
GTX86945
Overview
- SupplierGeneTex
- Product NameCaspase 9 (cleaved Asp315) antibody
- Delivery Days Customer9
- Antibody SpecificityCaspase 9 (cleaved Asp315) antibody detects endogenous levels of fragment of activated Caspase 9 resulting from cleavage adjacent to Asp315.
- Application Supplier NoteWB: 1:500~1:1000. IHC-P: 1:50~1:100. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- FormulationLiquid
- Gene ID842
- Target nameCASP9
- Target descriptioncaspase 9
- Target synonymsAPAF3; APAF-3; apoptotic protease activating factor 3; apoptotic protease MCH-6; caspase 9, apoptosis-related cysteine peptidase; caspase-9; ICE-LAP6; ICE-like apoptotic protease 6; MCH6; PPP1R56; protein phosphatase 1, regulatory subunit 56
- Protein IDP55211
- Protein NameCaspase-9
- Scientific DescriptionThis gene encodes a member of the cysteine-aspartic acid protease (caspase) family. Sequential activation of caspases plays a central role in the execution-phase of cell apoptosis. Caspases exist as inactive proenzymes which undergo proteolytic processing at conserved aspartic residues to produce two subunits, large and small, that dimerize to form the active enzyme. This protein can undergo autoproteolytic processing and activation by the apoptosome, a protein complex of cytochrome c and the apoptotic peptidase activating factor 1; this step is thought to be one of the earliest in the caspase activation cascade. This protein is thought to play a central role in apoptosis and to be a tumor suppressor. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2013]
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203